DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 52 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $2,643,000 | -46.0% | 131,100 | -0.1% | 0.00% | -50.0% |
Q2 2021 | $4,896,000 | +29.7% | 131,200 | -11.1% | 0.01% | +20.0% |
Q1 2021 | $3,775,000 | -75.1% | 147,645 | -78.5% | 0.01% | -68.8% |
Q4 2020 | $15,132,000 | -26.7% | 686,878 | -40.2% | 0.02% | -23.8% |
Q3 2020 | $20,651,000 | -10.7% | 1,147,900 | +26.1% | 0.02% | +5.0% |
Q2 2020 | $23,119,000 | +65.8% | 910,200 | +19.9% | 0.02% | +42.9% |
Q1 2020 | $13,945,000 | -36.2% | 759,100 | -23.5% | 0.01% | -17.6% |
Q4 2019 | $21,863,000 | +213.7% | 992,400 | +104.4% | 0.02% | +183.3% |
Q3 2019 | $6,970,000 | +91.6% | 485,400 | +34.6% | 0.01% | +200.0% |
Q2 2018 | $3,638,000 | +31.5% | 360,500 | +24.6% | 0.00% | -33.3% |
Q1 2018 | $2,767,000 | -45.3% | 289,400 | -48.3% | 0.00% | -50.0% |
Q4 2017 | $5,060,000 | +87.4% | 560,300 | +19.3% | 0.01% | +100.0% |
Q3 2017 | $2,700,000 | +92.2% | 469,600 | +6.0% | 0.00% | +50.0% |
Q2 2017 | $1,405,000 | -1.3% | 443,100 | +5.9% | 0.00% | 0.0% |
Q1 2017 | $1,423,000 | +20.9% | 418,500 | +2.4% | 0.00% | 0.0% |
Q4 2016 | $1,177,000 | -38.2% | 408,682 | +26.1% | 0.00% | -33.3% |
Q3 2016 | $1,905,000 | +739.2% | 324,000 | +328.6% | 0.00% | – |
Q2 2016 | $227,000 | +41.9% | 75,600 | +152.8% | 0.00% | – |
Q1 2016 | $160,000 | -81.4% | 29,900 | -51.5% | 0.00% | -100.0% |
Q2 2015 | $861,000 | +184.2% | 61,700 | +389.7% | 0.00% | +100.0% |
Q1 2015 | $303,000 | – | 12,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|